Elastomeric infusion pump market seen reaching $2.11 billion by 2030

The elastomeric infusion pump market is projected to grow from $1.47 billion in 2025 to $2.11 billion by 2030, driven by chronic disease, home care, and outpatient treatment demand. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Elastomeric infusion pumps support portable, steady drug delivery without electricity or batteries. - The market’s growth reflects broader demand for home-based care, outpatient infusion, and lower-cost alternatives to hospital stays. - Rising chronic illness and pain management needs are expanding the use case for disposable infusion devices.

What happened: - The Business Research Company said the global elastomeric infusion pump market will rise from $1.47 billion in 2025 to $1.58 billion in 2026. - The report projects the market will reach $2.11 billion by 2030. - The report pegs 2025-2026 growth at a 7.8% CAGR and 2026-2030 growth at 7.4%. - The forecast comes from The Business Research Company’s Elastomeric Infusion Pump Global Market Report 2026.

The details: - Elastomeric infusion pumps are compact, disposable medical devices that use pressure from an elastic reservoir to deliver fluids at a controlled rate. - The devices are portable because they do not require electricity or batteries. - Recent growth has been driven by chronic diseases requiring long-term infusion therapy, increased hospital intravenous treatments, wider use of disposable devices to reduce infections, and growth in oncology and pain management therapies. - The report says future growth will come from home healthcare and outpatient infusion therapy, patient-centric portable delivery devices, shorter hospital stays, lower healthcare costs, personalized medicine, and targeted drug delivery technologies. - The report also points to smart drug delivery systems linked to patient data platforms, biodegradable pump materials, and cloud-based monitoring for adherence tracking as emerging trends. - Chronic pain is a major demand driver because elastomeric pumps can provide continuous doses of pain medication for long-term management. - Arthritis Australia reported that about 5.39 million Australians will have arthritis in 2025, a 31% increase from previous years. - The Australian Department of Health and Aged Care said 277,612 people had access to Home Care Packages in 2023, up 17% from 2022. - The UK’s Office for National Statistics reported healthcare expenditure of about $370.71 billion (£317 billion) in 2024, up 6.5% from the prior year.

Between the lines: - The forecast suggests hospitals are not the only growth engine for infusion devices; care is shifting toward the home and outpatient settings. - The emphasis on disposable, portable, and potentially biodegradable products points to pressure on manufacturers to balance infection control, convenience, and sustainability. - North America led the market in 2025 because of established healthcare infrastructure and adoption of advanced devices. - Asia-Pacific is expected to be the fastest-growing region as healthcare spending rises, chronic disease rates increase, and home care expands.

What’s next: - The report expects market adoption to keep rising as providers look for devices that reduce hospital time and support self-managed care. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, and hotspot infographics. - The company offers a free sample report and the full market report.

The bottom line: - Elastomeric infusion pumps are moving from a niche device category to a broader care-enablement market tied to chronic disease, home treatment, and cost pressure.